News:

FDA delays proposal on patient drug information
Am J Health Syst Pharm 1995 52: 355-356.  

Fluvoxamine gains approval for obsessive-compulsive disorder
Am J Health Syst Pharm 1995 52: 355.  

Tighter safety controls needed over clinical trials, says FDA
Am J Health Syst Pharm 1995 52: 357. [Order Full Text via Infotrieve]  

Valproate and carbamazepine join lithium as primary treatments for bipolar disorder
Am J Health Syst Pharm 1995 52: 358.  

FDA set to expand pediatric information in drug product labeling
Am J Health Syst Pharm 1995 52: 358.  

Extra care urged in use of sumatriptan
Am J Health Syst Pharm 1995 52: 361. [Order Full Text via Infotrieve]  

Articles:

NE Cahill

The cost of complying with OSHA's bloodborne pathogens regulations
Am J Health Syst Pharm 1995 52: 362-364. [Order Full Text via Infotrieve]  

JA Graham and LA Zanetti

Role of beta-adrenergic-receptor antagonists with intrinsic sympathomimetic activity
Am J Health Syst Pharm 1995 52: 365-366. [Order Full Text via Infotrieve]  

Understanding and preventing drug misadventures. Proceedings of a conference. Chantilly, Virginia, October 21-23, 1994
Am J Health Syst Pharm 1995 52: 369-416. [Order Full Text via Infotrieve]  

Manasse HR, Jr

Toward defining and applying a higher standard of quality for medication use in the United States
Am J Health Syst Pharm 1995 52: 374-379. [Order Full Text via Infotrieve]  

LL Leape

Preventing adverse drug events
Am J Health Syst Pharm 1995 52: 379-382. [Order Full Text via Infotrieve]  

WO Robertson

Errors in prescribing
Am J Health Syst Pharm 1995 52: 382-385. [Order Full Text via Infotrieve]  

WN Kelly

Pharmacy contributions to adverse medication events
Am J Health Syst Pharm 1995 52: 385-390. [Order Full Text via Infotrieve]  

GA Pepper

Errors in drug administration by nurses
Am J Health Syst Pharm 1995 52: 390-395. [Order Full Text via Infotrieve]  

MR Cohen

Drug product characteristics that foster drug-use-system errors
Am J Health Syst Pharm 1995 52: 395-399. [Order Full Text via Infotrieve]  

KN Barker and EL Allan

Research on drug-use-system errors
Am J Health Syst Pharm 1995 52: 400-403. [Order Full Text via Infotrieve]  

BK Redman

Drug misadventuring as an issue in the ethics of leadership
Am J Health Syst Pharm 1995 52: 404-405. [Order Full Text via Infotrieve]  

ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy
Am J Health Syst Pharm 1995 52: 417-419. [Order Full Text via Infotrieve]  

S George and AH Rahi

Thrombocytopenia associated with diclofenac therapy
Am J Health Syst Pharm 1995 52: 420-421. [Order Full Text via Infotrieve]  

L Green and Minor, JR

Gene therapy for treating HIV infection may be an option
Am J Health Syst Pharm 1995 52: 423.  

DS North and GW Marman

Realities of the fluoxetine-to-sertraline switch
Am J Health Syst Pharm 1995 52: 424. [Order Full Text via Infotrieve]  

Editorials:

CE Myers

Needed: an interdisciplinary approach to drug misadventures
Am J Health Syst Pharm 1995 52: 367. [Order Full Text via Infotrieve]  

Letters:

ML Avent, P Gal, JL Ransom, and J Fulp

Colored deposit left in endotracheal tubes by ipratropium bromide
Am J Health Syst Pharm 1995 52: 421. [Order Full Text via Infotrieve]  

RG Fiscella and P Aramwit

Ganciclovir for intravitreal injection
Am J Health Syst Pharm 1995 52: 422. [Order Full Text via Infotrieve]  

D DeNunzio

Case presentations and staff development
Am J Health Syst Pharm 1995 52: 422.  

T Schleis

Realities of the fluoxetine-to-sertraline switch
Am J Health Syst Pharm 1995 52: 423. [Order Full Text via Infotrieve]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.